Figures and Tables

From the following article:

Leukotriene modifiers as potential therapeutics for cardiovascular disease

Colin D. Funk

Nature Reviews Drug Discovery 4, 664-672 (August 2005)

doi:10.1038/nrd1796

Figure 1 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Figure 1

Leukotriene biosynthetic cascade.

Figure 2 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Figure 2

Various members of the three classes of leukotriene-modifier drugs.

Figure 3 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Figure 3

Genetic variants in the 5-lipoxygenase/leukotriene pathway.

Figure 4 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Figure 4

Model for 5-lipoxygenase/leukotriene pathway involvement in aortic aneurysm and adventitial inflammation pathogenesis.

Table 1 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Table 1

Clinical pharmacology of the leukotriene modifiers

Table 2 - Leukotriene modifiers as potential therapeutics for cardiovascular disease

Table 2

Genetics of 5-lipoxygenase/leukotriene pathway and CVD